Early pain-dominant consult
Start with Modules 2 and 7 when the main job is first-line medical management, symptom relief, and setting a review plan before over-escalating.
InsideHer Learning
A clinician-facing course on consult sequencing, medical treatment, referral thresholds, surgery, fertility-priority care, and multidisciplinary support through April 2026.
Return to All Endometriosis CoursesCourse Overview
This course is written for clinicians and allied teams who need a practical framework for initial medical management, imaging and diagnostic escalation, specialist referral, surgical decision-making, postoperative planning, and persistent-pain support.
At A Glance
Quick Start
This course works best when it helps you sort the management problem first, rather than collapsing every endometriosis visit into the same medical-versus-surgical debate.
Start with Modules 2 and 7 when the main job is first-line medical management, symptom relief, and setting a review plan before over-escalating.
Start with Modules 3 and 4 when bowel, bladder, ureter, deep dyspareunia, imaging findings, or prior treatment failure suggest the need for specialist surgical framing.
Start with Modules 5 and 7 when conception timing, ovarian reserve, endometrioma, ART planning, or prior surgery change the treatment logic.
Start with Modules 6 and 7 when recurrent flares, central sensitization concerns, pelvic floor dysfunction, repeated medication changes, or post-surgical pain persistence dominate.
Clinical Shortcut
Avoid defaulting to stronger suppressive therapy when the real decision is whether to move toward fertility assessment, ART, or a carefully selected surgical step.
Module 1
The initial clinical task is to identify the dominant problem, not simply confirm that pelvic pain exists. The treatment conversation changes when the burden is driven by cyclical pain, heavy bleeding, bowel symptoms, urinary symptoms, deep dyspareunia, infertility, or persistent non-cyclical pain.
Symptom pattern, impact on function, desire for fertility, prior treatment exposure, and whether deep disease or organ involvement is plausible.
Heavy bleeding and iron-risk, bowel and bladder patterning, sex-related pain, and the distinction between cyclical pain and persistent pelvic pain.
Explicitly naming the treatment goal: symptom suppression, diagnosis clarification, disease mapping, fertility planning, or management of treatment failure.
Clinical Position
Combined hormonal contraceptives and progestogens remain standard early options for pain suppression, but the presence of infertility, possible deep disease, endometrioma, or persistent pain after prior treatment changes the value of further empirical therapy.
Module 2
First-line management usually combines symptom relief with a reversible hormonal option when appropriate. The objective is to reduce pain and cyclical burden while preserving the ability to review response and escalate thoughtfully if needed.
Simple analgesia and anti-inflammatory strategies may provide partial relief, but repeated rescue use without adequate function should trigger review rather than indefinite recycling.
Useful when the aim is cycle suppression and pain reduction, particularly when contraception is also desired and there are no contraindications.
Tablets, LNG-IUS, implant, or injectable options may fit when estrogen is not ideal, tolerability is better, or a longer-acting approach is preferred.
Guardrail
Partial response, non-response, or poor tolerability should not be framed as treatment failure in the patient. It may simply mean the dominant pain driver is different, the disease is more complex, or fertility priorities require a different pathway.
Module 3
Imaging and referral should not be treated as optional admin steps when the symptom pattern suggests complexity. NICE recommends specialist referral for suspected or confirmed endometrioma, deep endometriosis including bowel, bladder or ureter involvement, and extra-pelvic disease.
Specialist transvaginal ultrasound or pelvic MRI may help diagnose and define the extent of deep disease when interpreted by clinicians with appropriate expertise.
Consider laparoscopy for diagnosis even when ultrasound or MRI are normal if clinical suspicion remains meaningful and diagnostic clarification would change management.
Bowel, bladder, ureter, extra-pelvic disease, or larger endometrioma features justify earlier specialist service framing rather than prolonged empirical cycling.
Clinical Position
A negative scan should not end the conversation when symptom burden remains high and management decisions still hinge on diagnostic certainty, disease mapping, or surgical planning.
Module 4
Surgical management should be presented in terms of indication, expected gain, and postoperative plan. Excision or ablation may reduce pain for selected patients, but recurrence, persistent pain, and follow-up needs remain clinically important.
Diagnosis, pain reduction, endometrioma management, deep disease treatment, or a fertility-linked reason.
Which symptom or anatomical problem is surgery expected to improve, and which drivers may remain?
Deep disease involving bowel, bladder, or ureter needs the correct specialist service and operative planning.
Consider postoperative hormonal treatment for secondary prevention when fertility is not the immediate objective.
Guardrail
Overpromising pain resolution creates avoidable harm. Patients need honest discussion about the chance of partial response, symptom recurrence, and the role of postoperative care.
Module 5
Once fertility is the priority, the question changes from “How do we suppress symptoms?” to “What gets this patient closest to pregnancy while respecting symptom burden, ovarian reserve, anatomy, time, and prior treatment exposure?”
Hormonal suppression is not used to improve spontaneous conception while actively trying to conceive, even though it may still have been appropriate earlier for symptom control.
Endometrioma surgery may reduce ovarian reserve, so pre-ART surgery should be justified by pain, access, anatomy, or individualized reproductive reasoning rather than habit alone.
In some contexts, assisted reproduction is more clinically coherent than another cycle of suppression or another surgery, especially when other infertility factors coexist.
Clinical Position
The patient’s age, history, prior surgeries, endometrioma characteristics, tubal factors, semen factors, and access to fertility care often matter more than the instinct to keep intensifying symptom-directed suppression.
Module 6
Persistent pain after first-line therapy or surgery should trigger phenotype review, not only stronger escalation. NICE emphasizes access to multidisciplinary pain management, and broader care remains clinically appropriate when quality of life is substantially affected.
Consider whether pelvic floor dysfunction, centralized pain, bowel overlap, bladder symptoms, musculoskeletal factors, or sexual pain are sustaining the burden.
Pain management input can coexist with gynecology treatment and may be especially useful when repeated medical or surgical steps are not restoring function.
Pelvic health, movement support, psychology, and nutritional care should be framed as quality-of-life and function supports rather than substitutes for disease recognition.
Guardrail
Guideline groups remain cautious about specific non-pharmacological modalities because of weak or heterogeneous evidence. That still leaves room for multidisciplinary care when it is aligned with symptom pattern, function, and patient goals.
Module 7
The strongest clinical plans are explicit about sequence, stopping rules, review points, and onward referral triggers. Patients cope better when the pathway is visible.
Pain suppression, bleeding control, diagnostic clarification, fertility progression, or persistent-pain support.
Usually analgesia plus an appropriate hormonal option unless fertility or complexity changes that logic.
Deep disease features, inadequate response, poor tolerability, persistent dysfunction, or fertility-priority change.
Pain days, function, bleeding burden, sleep, work or study participation, and patient-reported meaningful benefit.
Clinical Reminder
Sudden severe pain, unusually heavy bleeding, progressive urinary or bowel symptoms, and systemic features should prompt medical review and reconsideration of whether the current management frame is still appropriate.
InsideHer Reminder
Visible logic, shared decision-making, and planned review usually improve care quality more than reflex escalation alone.